National Survey on Drug Use and Health
National Survey on Drug Use and Health (NSDUH) is a significant survey conducted annually in the United States by the Substance Abuse and Mental Health Services Administration (SAMHSA), a branch of the U.S. Department of Health and Human Services. The survey collects data on the use of tobacco, alcohol, illicit drugs, and mental health in the United States.
Overview[edit | edit source]
The NSDUH began in 1971 as the National Household Survey on Drug Abuse (NHSDA). Its primary goal is to provide yearly national and state-level estimates of drug, alcohol, and tobacco use, mental health and other health-related issues in the population aged 12 and older.
Methodology[edit | edit source]
The NSDUH uses a complex, multistage area probability sample design to select a representative sample of the U.S. civilian, non-institutionalized population aged 12 years old or older for participation in the survey. The survey involves interviews with a nationally representative sample of about 70,000 randomly selected individuals across the United States.
Findings[edit | edit source]
The NSDUH provides critical information that helps to guide policies and programs aimed at preventing substance abuse and mental disorders. The survey's findings are used by government agencies, researchers, policy makers, and others to understand the impact of substance use and mental health issues on health and well-being.
Criticisms[edit | edit source]
While the NSDUH is a valuable tool for understanding drug use and mental health in the United States, it has been criticized for its reliance on self-reported data, which may be subject to bias. Additionally, the survey does not include individuals who are homeless, institutionalized, or in the military, which may limit the generalizability of its findings.
See also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD